Transvaginal Mesh Patch

Surgeons implant transvaginal mesh patches into female patients to help support weak or damaged vaginal walls. The devices are typically used in patients who suffer from pelvic organ prolaspse (POS) or stress urinary incontinence (SUI).

Unfortunately, some patients receiving the transvaginal mesh patch have experienced serious internal injuries including infection, urinary issues, and other complications involving persistent pain and discomfort. After receiving over 1,500 complaints of such side effects from patients implanted with the transvaginal mesh patch, the FDA acknowledged that the device’s risks outweighed its benefits, and began warning physicians about using this uncertain device only as a last option.

There are a variety of transvaginal mesh patch manufacturers including Johnson and Johnson, Bard, American Medical Systems (AMS) and Boston Scientific. Transvaginal mesh patch recipients began filing lawsuits against these manufacturers when a clinical study was halted after revealing over 15 percent of participants experienced a serious complication called “erosion,” a condition in which a patient’s skin splits, allowing the mesh to protrude.

If you or someone you know has suffered from dangerous side effects after receiving a transvaginal mesh patch, you may be entitled to compensation. Contact us today to discuss your legal options.